A Study of CS3005 in Advanced Solid Tumors

NCT04233060 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: CS3005

Sponsor

CStone Pharmaceuticals